http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990073908-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
| filingDate | 1998-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990073908-A |
| titleOfInvention | Method for treating proliferative disease using 2- (ㄲ (3-hydroxypropyl) amino ㅒ -6-benzylamino) -9-isopropylpurine compound and pharmaceutically acceptable salts thereof |
| abstract | The present invention relates to a method of treating a proliferative disease using a 2-([3-hydroxypropyl) amino] -6-benzylamino) -9-isopropylpurine compound and a pharmaceutically acceptable salt thereof.n n n Applying the compound to proliferative diseases such as cancer or leukemia, OC (olomousin) induced synthetic CDKI is capable of inhibiting cdk7 kinase in both in vitro and in vivo conditions It can be seen. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010077073-A |
| priorityDate | 1998-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.